Dr Mary Collins
University of Cambridge
Subtitle
Developments in Protein Interaction Analysis
Teaser...
9 - 12 September, 2024
Kistamässan Exhibition & Congress Centre Kista, Sweden
Register to attend
By attending, you confirm you are not located in or a national of a sanctioned country or region, are not a restricted party, and acknowledge that this training may include content subject to U.S. and other export control and sanctions laws. Sharing the content, whether verbally, visually, electronically, or via screen-sharing during webinars must comply with these laws. Allowing unauthorized or restricted individuals to view or participate is a violation and may result in civil and/or criminal penalties.
Subtitle
Process development virtual summit 2026
Get the latest process development methods and data from your peers.
Meet your next milestone faster.
19 – 21 May, 2026
Complete this form to watch all session on-demand! Thank you
Register your details below.
By attending, you confirm you are not located in or a national of a sanctioned country or region, are not a restricted party, and acknowledge that this training may include content subject to U.S. and other export control and sanctions laws. Sharing the content, whether verbally, visually, electronically, or via screen-sharing during webinars must comply with these laws. Allowing unauthorized or restricted individuals to view or participate is a violation and may result in civil and/or criminal penalties.
Join us for our three-day process development virtual summit 19-21 May, 2026.
Connect with industry experts and get inspired by the latest technology and tips so you can make confident process decisions from preclinical through scale-up–for any modality, stage, or goal. Join us for 1 session or 20.
High-level agenda
Day 1: Leverage analytics to optimize
Learn about connected laboratories, computational fluid dynamics, and upstream and downstream strategies to help meet timeline and productivity requirements.
Day 2: Meet your CQAs and scale faster
Discover ways to streamline purification workflows for mAbs, recombinant proteins and antibody variants while ensuring your decisions will hold as you scale.
Day 3: Level-up advanced therapeutics
Hear the latest on AAV, mRNA, LNPs, and cell therapy, and learn how to adapt to the evolving landscape of process development for novel modalities.
Registration is free of charge—see you there!
Researchers all over the world are invited to attend DiPIA 2024
9 - 22 September, 2024
Kistamässan Exhibition & Congress Centre Kista, Sweden
What is DiPIA?
DiPIA, or Developments in Protein Interaction Analysis, is a global scientific conference hosted by Cytiva. We bring peers together from across the industry to share best practices, research, and new applications. This conference is dedicated to the surface plasmon resonance (SPR) technology as featured in our Biacore™ SPR systems.
The theme for this year’s DiPIA is Exploring the Unknown. Expect to see the past, present, and future of exploration. Stay tuned for more updates on the theme as the event nears.
Ticket Prices
Standard entry tickets: €850
Price includes local VAT of 25%. Payments will be handled by our partners at Pro-SPR within 5 business days of form fill.
Tickets are strictly limited so act fast to secure your place. Fill in the form on this page to register for attendance. Our partners at Pro-SPR will be in touch to confirm your spot and handle payments. The registration fee includes attendance to the event, lunches provided, the welcome reception and the gala dinner.
This event is organized by Cytiva. The registration fee includes attendance to the event, lunches provided, the welcome reception and the gala dinner. Accommodation may be allocated by Cytiva but is not included in the event fee. Registrant information will be passed on to our partners at Pro-SPR and Cvent to help organize this event and provide a smoother experience for you. Information will not be used for any purpose outside of DiPIA 2024.
SUPRAdisc™ II depth filter modules
Next generation in depth filter module technology for bioprocess clarification applications.
The SUPRAdisc™ II module design combines the filtration performance of Seitz™ media and the structural robustness of interlocking dual drainage plates.
Agenda
Agenda and schedules are subject to change. All times listed are in EDT.
Tuesday, 19 May 2026 - Leverage analytics and optimize
Learn about connected laboratories, computational fluid dynamics, and upstream and downstream strategies to help meet timeline and productivity requirements.
| Time | Topic | Speakers |
|---|---|---|
|
8:00 AM |
From innovation to impact: The future of bioprocess development across upstream and downstream |
Henrik Ihre; Andreas Castan |
|
8:30 AM |
Driving bioprocess optimization through connected laboratory environments and advanced analytics |
Nathan Todd; Nicole Camara |
|
9:00 AM |
Using computational fluid dynamics (CFD) to design scalable bioreactor processes |
Nagaraj Rao |
|
9:30 AM |
BREAK |
|
|
10:15 AM |
Integrating synthetic biology and AI to advance biologics production |
Alec Nielsen |
|
10:45 AM |
How perfusion in seed train bioreactors can simplify upstream processes |
Jennie Gullick |
|
11:15 AM |
Dynamic perfusion as a simplified strategy for continuous monoclonal antibody production |
Thomas Falkman |
|
11:45 AM |
PANEL: Chromatography polishing: Challenges, shifts, and solutions |
Niklas Jungnelius, Eva Heldin and Jakob Liderfelt |
|
12:10 PM |
CLOSE |
|
Wednesday, 20 May 2026 - Meet your Critical Quality Attributes (CQAs) and scale faster
Discover ways to streamline purification workflows for mAbs, recombinant proteins and antibody variants while ensuring your decisions will hold as you scale.
| Time | Topic | Speaker |
|---|---|---|
|
8:00 AM |
OPEN |
|
|
8:05 AM |
An adaptable, modern affinity chromatography system to speed time to market for new recombinant protein products |
Phillip Elliott |
|
8:45 AM |
Evaluation of MabSelect™ VH3 affinity resin for selective purification of antibody-based protein scaffolds |
Anthony Ransdell |
|
9:15 AM |
Streamlining purification of asymmetric multi-specific antibodies at research scale with MabSelect™ mild elution |
Ian Scott |
|
9:45 AM |
Improved clearance of host cell proteins after virus inactivation |
Matthew Becker |
|
10:15 AM |
BREAK |
|
|
10:25 AM |
From discovery to manufacturing: Smoother handoffs, faster delivery |
Andrew Falconridge |
|
10:50 AM |
Faster paths to biosimilar equivalence: Turning new US & EU guidance into development advantage |
Sandra Racordon-Pape |
|
11:15 AM |
Scale your chromatography with confidence: A practical roadmap for column sizing, system selection, and GxP readiness |
Martin Sichting |
|
11:55 AM |
Reducing timelines and development costs through predictable bioreactor scale‑up using the Xcellerex X‑platform |
Kerem Irfan |
|
12:25 PM |
CLOSE |
|
Thursday, 21 May 2026 - Level-up advanced therapeutics
Hear the latest on AAV, mRNA, LNPs, and cell therapy, and learn how to adapt to the evolving landscape of process development for novel modalities.
| Time | Topic | Speaker |
|---|---|---|
|
8:00 AM |
OPEN |
|
|
8:05 AM |
Genomic medicine at an inflection point |
Emmanuelle Cameau |
|
8:35 AM |
Scaling AAV purification: UF/DF technologies that deliver |
Amar Joshi; Luke McCarney |
|
9:05 AM |
Futureproofing AAV processes: Viral safety considerations in process development |
Amar Joshi |
|
9:35 AM |
How cell therapy's fundamentally different model impacts patients |
Bill Shingleton |
|
10:00 AM |
BREAK |
|
|
10:10 AM |
Enhancing mRNA-LNP downstream processing via single-pass tangential flow filtration |
Roman Kondra |
|
10:40 AM |
Role of membrane chemistry and filter format in tangential flow filtration of mRNA and lipid nanoparticles |
Divakara Uppu |
|
11:10 AM |
Sterilizing-grade filtration of mRNA encapsulated lipid-nanoparticles |
Logan Ingalls |
|
11:35 AM |
PFAS‑free* Supor™ Prime sterile filtration: polysorbate transmission performance |
Kyle Jones |
|
12:00 PM |
CLOSE |
|
Agenda single day
Agenda and schedules are subject to change. All times listed are in CEST.
| Time | Details | |
|---|---|---|
| 8:30 - 9:00 | Welcome and opening | |
| 9:00 - 10:30 | Stephan Poetsch | ÄKTA™ chromatography systems family, system specifications and UNICORN with the new developments in the portfolio |
| 10:30 - 11:00 | Break | |
| 11:00 - 12:00 | Stephan Poetsch | ÄKTA™ basic care and troubleshooting - To prevent problems during protein purification |
| 12:00 - 13:30 | Christin Radon and Emeric Gueneau | Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation |
| 13:30 - 15:00 | Anja Drescher and Mike Murphy | Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison |
Meet our speakers
-
Michael Anderson
Chief Technology Officer, Danaher
Read the biography -
Emily Harrison
Associate Scientist, Product Development, Cytiva
Read the biography -
David Miller
Senior Director of Innovation Advocacy, Cytiva
Read the biography -
Stella Park
Associate Scientist, Product Develipment, Cytiva
Read the biography -
Michael Anderson
Chief Technology Officer, Danaher
Read the biography -
Emily Harrison
Associate Scientist, Product Development, Cytiva
Read the biography -
David Miller
Senior Director of Innovation Advocacy, Cytiva
Read the biography -
Stella Park
Associate Scientist, Product Develipment, Cytiva
Read the biography
Our location
Want to get a feel for what to expect?
Missed the previous Process development virtual summits?
Catch up on our technical talks - from upstream to downstream for protein-based and gene therapy processes.
In this presentation Josefin Bolik explained how purification platforms used for mAbs need to be adopted for antibody variants to simplify protocols and improve purity and yield. She presents strategies for purifying bispecific antibodies and antibody fragments using MabSelect™ VH3 resin and MabSelect™ VL resin.
Testimonials
-
“It was amazing to get the chance to listen into the discussions and presentations organized as part of the summit. Of special importance was the fact that this open summit gave a fresher an understanding of the future and present of the industry allowing me the chance to future proof myself by focused skill development.”
-
DiPIA 2024 brought together leaders in protein interaction analysis. The sessions on SPR’s evolution were fascinating and opened up new possibilities for my work.
Dr John Davis
Institute for Biological Research
-
Attending DiPIA 2024 was incredibly inspiring! Connecting with global experts in SPR technology gave me new insights and ideas for my research.
Dr Anna Collins
University of Cambridge
-
DiPIA 2024 brought together leaders in protein interaction analysis. The sessions on SPR’s evolution were fascinating and opened up new possibilities for my work.
Dr Steven Davis
Institute for Biological Research
-
Attending DiPIA 2024 was incredibly inspiring! Connecting with global experts in SPR technology gave me new insights and ideas for my research.
Dr Mary Collins
University of Cambridge
-
DiPIA 2024 brought together leaders in protein interaction analysis. The sessions on SPR’s evolution were fascinating and opened up new possibilities for my work.
Dr John Davis
Institute for Biological Research